BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

651 related articles for article (PubMed ID: 30096312)

  • 1. Divergent Routes toward Wnt and R-spondin Niche Independency during Human Gastric Carcinogenesis.
    Nanki K; Toshimitsu K; Takano A; Fujii M; Shimokawa M; Ohta Y; Matano M; Seino T; Nishikori S; Ishikawa K; Kawasaki K; Togasaki K; Takahashi S; Sukawa Y; Ishida H; Sugimoto S; Kawakubo H; Kim J; Kitagawa Y; Sekine S; Koo BK; Kanai T; Sato T
    Cell; 2018 Aug; 174(4):856-869.e17. PubMed ID: 30096312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wnt Signaling Shapes the Histologic Variation in Diffuse Gastric Cancer.
    Togasaki K; Sugimoto S; Ohta Y; Nanki K; Matano M; Takahashi S; Fujii M; Kanai T; Sato T
    Gastroenterology; 2021 Feb; 160(3):823-830. PubMed ID: 33217450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome Engineering of Human Colon-Derived Organoids to Develop a Model of Traditional Serrated Adenoma.
    Kawasaki K; Fujii M; Sugimoto S; Ishikawa K; Matano M; Ohta Y; Toshimitsu K; Takahashi S; Hosoe N; Sekine S; Kanai T; Sato T
    Gastroenterology; 2020 Feb; 158(3):638-651.e8. PubMed ID: 31622618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Pancreatic Tumor Organoids Reveal Loss of Stem Cell Niche Factor Dependence during Disease Progression.
    Seino T; Kawasaki S; Shimokawa M; Tamagawa H; Toshimitsu K; Fujii M; Ohta Y; Matano M; Nanki K; Kawasaki K; Takahashi S; Sugimoto S; Iwasaki E; Takagi J; Itoi T; Kitago M; Kitagawa Y; Kanai T; Sato T
    Cell Stem Cell; 2018 Mar; 22(3):454-467.e6. PubMed ID: 29337182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RSPO3 expands intestinal stem cell and niche compartments and drives tumorigenesis.
    Hilkens J; Timmer NC; Boer M; Ikink GJ; Schewe M; Sacchetti A; Koppens MAJ; Song JY; Bakker ERM
    Gut; 2017 Jun; 66(6):1095-1105. PubMed ID: 27511199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-cell transcriptome analysis identifies distinct cell types and niche signaling in a primary gastric organoid model.
    Chen J; Lau BT; Andor N; Grimes SM; Handy C; Wood-Bouwens C; Ji HP
    Sci Rep; 2019 Mar; 9(1):4536. PubMed ID: 30872643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Organoid-Based Preclinical Model of Human Gastric Cancer.
    Steele NG; Chakrabarti J; Wang J; Biesiada J; Holokai L; Chang J; Nowacki LM; Hawkins J; Mahe M; Sundaram N; Shroyer N; Medvedovic M; Helmrath M; Ahmad S; Zavros Y
    Cell Mol Gastroenterol Hepatol; 2019; 7(1):161-184. PubMed ID: 30522949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Colorectal Tumor Organoid Library Demonstrates Progressive Loss of Niche Factor Requirements during Tumorigenesis.
    Fujii M; Shimokawa M; Date S; Takano A; Matano M; Nanki K; Ohta Y; Toshimitsu K; Nakazato Y; Kawasaki K; Uraoka T; Watanabe T; Kanai T; Sato T
    Cell Stem Cell; 2016 Jun; 18(6):827-838. PubMed ID: 27212702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human gastric cancer modelling using organoids.
    Seidlitz T; Merker SR; Rothe A; Zakrzewski F; von Neubeck C; Grützmann K; Sommer U; Schweitzer C; Schölch S; Uhlemann H; Gaebler AM; Werner K; Krause M; Baretton GB; Welsch T; Koo BK; Aust DE; Klink B; Weitz J; Stange DE
    Gut; 2019 Feb; 68(2):207-217. PubMed ID: 29703791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Patient-Derived Gastric Cancer Organoids from Endoscopic Biopsies and Surgical Tissues.
    Gao M; Lin M; Rao M; Thompson H; Hirai K; Choi M; Georgakis GV; Sasson AR; Bucobo JC; Tzimas D; D'Souza LS; Buscaglia JM; Davis J; Shroyer KR; Li J; Powers S; Kim J
    Ann Surg Oncol; 2018 Sep; 25(9):2767-2775. PubMed ID: 30003451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer Types.
    Chartier C; Raval J; Axelrod F; Bond C; Cain J; Dee-Hoskins C; Ma S; Fischer MM; Shah J; Wei J; Ji M; Lam A; Stroud M; Yen WC; Yeung P; Cancilla B; O'Young G; Wang M; Kapoun AM; Lewicki J; Hoey T; Gurney A
    Cancer Res; 2016 Feb; 76(3):713-23. PubMed ID: 26719531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids.
    Matano M; Date S; Shimokawa M; Takano A; Fujii M; Ohta Y; Watanabe T; Kanai T; Sato T
    Nat Med; 2015 Mar; 21(3):256-62. PubMed ID: 25706875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling Wnt signaling by CRISPR-Cas9 genome editing recapitulates neoplasia in human Barrett epithelial organoids.
    Liu X; Cheng Y; Abraham JM; Wang Z; Wang Z; Ke X; Yan R; Shin EJ; Ngamruengphong S; Khashab MA; Zhang G; McNamara G; Ewald AJ; Lin D; Liu Z; Meltzer SJ
    Cancer Lett; 2018 Nov; 436():109-118. PubMed ID: 30144514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse Models of Human Gastric Cancer Subtypes With Stomach-Specific CreERT2-Mediated Pathway Alterations.
    Seidlitz T; Chen YT; Uhlemann H; Schölch S; Kochall S; Merker SR; Klimova A; Hennig A; Schweitzer C; Pape K; Baretton GB; Welsch T; Aust DE; Weitz J; Koo BK; Stange DE
    Gastroenterology; 2019 Dec; 157(6):1599-1614.e2. PubMed ID: 31585123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organoid Cultures as Preclinical Models of Non-Small Cell Lung Cancer.
    Shi R; Radulovich N; Ng C; Liu N; Notsuda H; Cabanero M; Martins-Filho SN; Raghavan V; Li Q; Mer AS; Rosen JC; Li M; Wang YH; Tamblyn L; Pham NA; Haibe-Kains B; Liu G; Moghal N; Tsao MS
    Clin Cancer Res; 2020 Mar; 26(5):1162-1174. PubMed ID: 31694835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic alterations in BCL2L1 and DLC1 contribute to drug sensitivity in gastric cancer.
    Park H; Cho SY; Kim H; Na D; Han JY; Chae J; Park C; Park OK; Min S; Kang J; Choi B; Min J; Kwon JY; Suh YS; Kong SH; Lee HJ; Liu ET; Kim JI; Kim S; Yang HK; Lee C
    Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12492-7. PubMed ID: 26401016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-omics analysis identifies pathways and genes involved in diffuse-type gastric carcinogenesis induced by E-cadherin, p53, and Smad4 loss in mice.
    Park JW; Kim MS; Voon DC; Kim SJ; Bae J; Mun DG; Ko SI; Kim HK; Lee SW; Kim DY
    Mol Carcinog; 2018 Jul; 57(7):947-954. PubMed ID: 29528141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organoid cultures of early-onset colorectal cancers reveal distinct and rare genetic profiles.
    Yan HHN; Siu HC; Ho SL; Yue SSK; Gao Y; Tsui WY; Chan D; Chan AS; Wong JWH; Man AHY; Lee BCH; Chan ASY; Chan AKW; Hui HS; Cheung AKL; Law WL; Lo OSH; Yuen ST; Clevers H; Leung SY
    Gut; 2020 Dec; 69(12):2165-2179. PubMed ID: 32217638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Generation of Organoids for Studying Wnt Signaling.
    Drost J; Artegiani B; Clevers H
    Methods Mol Biol; 2016; 1481():141-59. PubMed ID: 27590160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-195 inhibits human gastric cancer by directly targeting basic fibroblast growth factor.
    Wang J; Li L; Jiang M; Li Y
    Clin Transl Oncol; 2017 Nov; 19(11):1320-1328. PubMed ID: 28500362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.